Enanta Pharmaceuticals reported $8.33M in Selling and Administration Expenses for its first fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Selling And Administration Expenses Change
Abbvie ABBV:US $ 3.07B 228M
Acorda Therapeutics ACOR:US $ 32.27M 608K
Amgen AMGN:US $ 1.25B 519M
Anika Therapeutics ANIK:US $ 18.18M 3M
Arrowhead Research ARWR:US $ 16.19M 7.54M
AstraZeneca AZN:LN 2.57B 76M
Biocryst Pharmaceuticals BCRX:US $ 22.11M 1.13M
Biogen BIIB:US $ 637.3M 42.3M
Bristol Myers Squibb BMY:US $ 1.88B 215M
Clovis Oncology CLVS:US $ 29.94M 10.82M
Enanta Pharmaceuticals ENTA:US $ 8.33M 949K
Gilead Sciences GILD:US $ 1.34B 297M
GlaxoSmithKline GSK:LN 2.5B 183M
Halozyme Therapeutics HALO:US $ 11.06M 632K
Heron Therapeutics HRTX:US $ 24.81M 3.25M
Insmed INSM:US $ 51.55M 4.47M
Intercept Pharmaceuticals ICPT:US $ 57.65M 1.62M
IONIS PHARMACEUT IONS:US $ 61.2M 77.67M
Johnson & Johnson JNJ:US $ 6.07B 641M
Karyopharm Therapeutics KPTI:US $ 37.65M 3.72M
Ligand Pharmaceuticals LGND:US $ 14.71M 2.09M
Marinus Pharmaceuticals MRNS:US 10.38M 4.37M
Merk MRK:US $ 2.25B 376M
Neurocrine Biosciences NBIX:US $ 129M 22.5M
Novartis NOVN:VX 3.71B 190M
Novavax NVAX:US $ 63.19M 1.88M
Pfizer PFE:US $ 2.79B 134M
Ptc Therapeutics PTCT:US $ 68.88M 7.78M
Sarepta Therapeutics SRPT:US $ 71.13M 14.92M
Vertex Pharmaceuticals VRTX:US $ 194.67M 2.59M
Vital Therapies VTL:US $ 20.87M 17.85M
YTE INCY:US $ 153.79M 13.19M